Exponent, Inc. (EXPO) 2012年年度报告「NASDAQ」.pdf

1、 2012 Annual Report Dear Fellow Stockholders:2012 was another good year for Exponent during which we posted strong growth in revenues and earnings.During the year,we experienced strong demand from a broad set of proactive and reactive assignments,assisting over 2,000 clients on more than 7,000 proje

2、cts,utilizing greater than 90 different technical disciplines.The end result was that we billed over one million hours,and achieved 73 percent utilization.We closed the year with over 700 technical FTEs and continue to be recognized for our unparalleled technical talent including more than 400 docto

3、rates.Exponents market position has never been stronger.For the full year,total revenues increased 7%to$292.7 million and revenues before reimbursements were up 8%to$266.6 million.Net income improved 14%to$37.2 million,or$2.60 per diluted share,and EBITDA grew 12%to$66.1 million.During 2012,we gener

4、ated$48.5 million in cash flow from operations,repurchased$23.4 million of common stock,and closed the year with$134.1 million in cash,cash equivalents and short-term investments.Throughout 2012,we assisted a wide range of clients in addressing significant technological,health and environmental matt

5、ers by leveraging our breadth of disciplines and depth of engineering and scientific knowledge.We continued our work on several high-profile,major assignments during the year.We had notable performances in our environmental and health segment from our environmental sciences,ecological sciences,and c

6、hemical regulation and food safety practices.This work included the performance of environmental risk assessments for historical,existing and future operations.We also assisted a diverse set of clients with regulatory issues involving the use of chemicals.In our engineering and other scientific segm